| Gene/Protein Targets | a2 integrin, b1 integrin |
| Relevance: | Disease model for psoriasis; in vivo study of human a2 and b1 integrin transgene expression in skin. |
| Model Type: | Conditional, Transgenic Models |
| Genetic Background: | CBA/C57BL/6 |
| Zygosity: | Heterozygous |
| Phenotype Keywords: | Skin abnormalities |
| Disease Keywords: | Psoriasis |
| Production Details: | Involucrin-integrin transgene expression constructs were injected into fertilised oocytes from F1 hybrid CBA/C57BL/6 mice. Transgene-positive mice were back-crossed to generate individual founder lines. The a2 transgene founder line was mated to the b1 integrin founder line to generate mice expressing both a2 and b1 integrin transgenes. |
| References: | Carroll et al, 1995. Cell. 83:957-65. PMID: 8521519Read more |
| Notes: | The Inv-a2b1 mouse presents a phenotype very similar to human psoriasis, and is an ideal tool for study of the disease in vivo. Inv-a2b1 mice demonstrate three key features of human psoriasis; abnormal keratinocyte differentiation, epidermal hyperproliferation, and inflammatory skin lesions. The mouse has conditional expression of integrins under involucrin promoter giving tissue-specific suprabasal epidermal expression. For more psoriasis disease models, see also Inv-a3b1 mouse; Inv-a5b1 mouse; InvEE mouse. |
© Cancer Research Technology 2012